Sobre 2 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Discover the full record of transactions filed by Davis Todd C, Consejero. Director active across 5 companies, notably Ligand Pharmaceuticals INC. In total, 30 filings have been published. Split: 5 buys · 0 sell. Total volume traded: €602k. Activity tracked since 4 June 2021. The latest transaction was filed on 30 June 2026 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Davis Todd C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Davis Todd C is Administrateur and has 30 filings in total. Across the 30 filings tracked, the recent sampled filings run from 2021-06-07 to 2026-07-06, with EUR 602361 of buys and EUR 0 of sells. They are associated with Ligand Pharmaceuticals INC, Pelthos Therapeutics Inc., Biodelivery Sciences International INC, Vaxart, Inc. and Chromocell Therapeutics Corp.